What year was CuraGen incorporated and in what states?
CuraGen was incorporated in the State of Delaware in 1991.
When did CuraGen become a publicly traded company?
CuraGen Corporation went public on March 18, 1998.
Where is CuraGen's stock traded?
CuraGen is traded on the Nasdaq Global Market under the symbol CRGN.
Who is CuraGen's stock transfer agent and how do I contact them?
American Stock Transfer & Trust Company
59 Maiden Lane, Plaza Level
New York, NY 10038
Tel (800) 937-5449
Tel (718) 921-8124
URL www.amstock.com
What is CuraGen's fiscal year?
CuraGen's fiscal year begins on January 1 and ends on December 31.
Has CuraGen had any stock splits?
Yes, CuraGen's Board of Directors approved a two-for-one split of CuraGen's common on March 2, 2000. The common stock began trading on a split-adjusted basis on March 31, 2000.
How do I purchase CuraGen stock?
CuraGen's common stock can be bought or sold through a stockbroker or financial institution that offers brokerage services.
Who are the financial analysts that follow CuraGen?
Please visit the Analyst section for a listing of those firms and analysts that cover CuraGen.
Who is CuraGen's independent auditor?
Deloitte & Touche, LLP
Stamford, CT
How do I obtain a copy of CuraGen's annual report?
Please click here to download a PDF reprint of CuraGen's annual report. A hardcopy of CuraGen's annual report can requested from the Information Request section
Where can I access CuraGen's financial reports and other periodic SEC filings?
Who are the members of CuraGen's Board of Directors?
To see a complete list of CuraGen's Directors and their biographies, please visit the Board of Directors section.
How do I sign up to receive press releases automatically from CuraGen?
Please visit the Email alerts section where you can register to receive CuraGen's press releases via email, as well as sign up to be notified of new SEC filings and IR events.
How do I unsubscribe from CuraGen's email distribution list?
Please visit the Email alerts section to unsubscribe.
Who can I contact about specific investor relations issues?
If you are unable to find the information you are looking for about CuraGen on our website, you may contact:
Glenn Schulman, PharmD, MPH
Assistant Director of Investor Relations
CuraGen Corporation
322 East Main Street
Branford, CT 06405
Tel: (203) 481-1104
Email: gschulman@curagen.com
Do you have another question that hasn't been answered?
Please submit your question using the form below. Fields marked with an * are required.
